Orales Vinorelbin: Pharmakologie und Behandlungsergebnisse beim nichtkleinzelligen Bronchialkarzinom und Mammakarzinom

Marco Colleoni, Fernando Gaion, Giovanni Vicario, Patrizia Nelli, Francesca Pancheri, Gigliola Sgarbossa, Paolo Manente, Pain at tumor site after vinorelbine injection: description of an unexpected side effect. Tumori. ,vol. 81, pp. 194- 196 ,(1995) , 10.1177/030089169508100308

Sakai T, Kobayashi S, Dalrymple Pd, Wood Sg, Chasseaud Lf, Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Drug Research. ,vol. 43, pp. 1367- 1377 ,(1993)

C. Belani, E. E. Vokes, J. Craig, J. Hohneker, R. Rosenberg, S. Jones, M. Jahanzeb, R. Gralla, J. Bigley, Tuttle, Gralla, O'Rourke, Moinpour, Crawford, Viallet, Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: A preliminary report Seminars in Oncology. ,vol. 21, pp. 35- 41 ,(1994)

Laurent Nguyen, Brigitte Tranchand, Christian Puozzo, Philippe Variol, Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials British Journal of Clinical Pharmacology. ,vol. 53, pp. 459- 468 ,(2002) , 10.1046/J.1365-2125.2002.01581.X

Hiroyuki Kobayashi, Satoshi Kobayashi, Takashi Kuwabara, Jiro Kajita, CYP3A4 Is Mainly Responsibile for the Metabolism of a New Vinca Alkaloid, Vinorelbine, in Human Liver Microsomes Drug Metabolism and Disposition. ,vol. 28, pp. 1121- 1127 ,(2000)

S Jones, E Winer, C Vogel, L Laufman, L Hutchins, M O'Rourke, B Lembersky, D Budman, J Bigley, J Hohneker, Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. Journal of Clinical Oncology. ,vol. 13, pp. 2567- 2574 ,(1995) , 10.1200/JCO.1995.13.10.2567

G Liu, E Franssen, M I Fitch, E Warner, Patient preferences for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 110- 115 ,(1997) , 10.1200/JCO.1997.15.1.110

E K Rowinsky, D A Noe, D L Trump, E P Winer, V S Lucas, W A Wargin, J A Hohneker, B Lubejko, S E Sartorius, D S Ettinger, Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors. Journal of Clinical Oncology. ,vol. 12, pp. 1754- 1763 ,(1994) , 10.1200/JCO.1994.12.9.1754

Pierre Mangeney, R. Z. Andriamialisoa, Nicole Langlois, Yves Langlois, Pierre Potier, A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids. Journal of Organic Chemistry. ,vol. 44, pp. 3765- 3768 ,(1979) , 10.1021/JO01336A006

D Serin, M Verrill, A Jones, T Delozier, R Coleman, E-D Kreuser, K Mross, B Longerey, M Brandely, Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer : results of a multicentre phase II study British Journal of Cancer. ,vol. 92, pp. 1989- 1996 ,(2005) , 10.1038/SJ.BJC.6602588